about
Imiglucerase in the treatment of Gaucher disease: a history and perspectiveUnderstanding the natural history of Gaucher diseaseGaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolismThe French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients.The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher RegistryGaucher's disease and cancer: a sphingolipid perspectiveOsteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults.A reappraisal of Gaucher disease-diagnosis and disease management algorithms.Gaucher's disease: report of 11 cases with review of literature.Review of the safety and efficacy of imiglucerase treatment of Gaucher disease.Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent.A new framework for evaluating the health impacts of treatment for Gaucher disease type 1.Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.The history and accomplishments of the ICGG Gaucher registry.Gaucher disease: resetting the clinical and scientific agenda.Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?Morbidity and mortality in type B Niemann-Pick disease.Letter to the Editor on "Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options".
P2860
Q24631426-8F17CF75-3F92-42A9-9452-EDF4212851FEQ26865974-875961E9-0225-4B09-B65B-1BB1624EC130Q27013427-A4289E97-090C-4B97-BECA-37BB85CDFC3BQ33403714-48FD6F69-1BCF-4947-AB38-82D2ED495920Q33743729-2B4B637B-FB1F-47E2-BD65-1C8608ABBED5Q34333982-72A8199C-BA94-48DC-891E-C17091FE127AQ34482254-CF5193A5-F40D-4402-96F8-A8FA31A81ECDQ34683786-F8954C26-237F-46DB-BBFE-8EF90BB6CC06Q35605639-7A6B2E01-42AA-4FE5-BC72-0197F81D076CQ37354438-6E5B9C7F-A5AF-4DB6-B1F7-A6454CADC2B8Q37520646-0764F40B-9FE3-44F8-9478-A622DEA04B7DQ37655469-7211C7D9-76EB-46CE-A5F1-9B41ADB8CBDEQ38262722-D1617C71-C5B6-4B0C-886C-1AA1D8BA7C62Q38833111-F07FF332-7CED-4F18-9E75-07A037BB7DD8Q41652308-D35EFCAD-9A00-4B8C-8EDB-1A74D5A81158Q42331780-05328BDF-437E-4C75-8007-3F408E08F8AAQ43759628-0DC18BB4-09A3-4353-A2FD-1290E34C99CEQ45245202-72899112-A42A-473C-8C13-B3C968251B8BQ49587267-9966889A-9C51-41A7-95F9-43AAFBB21911
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Life expectancy in Gaucher disease type 1
@ast
Life expectancy in Gaucher disease type 1
@en
Life expectancy in Gaucher disease type 1
@nl
type
label
Life expectancy in Gaucher disease type 1
@ast
Life expectancy in Gaucher disease type 1
@en
Life expectancy in Gaucher disease type 1
@nl
prefLabel
Life expectancy in Gaucher disease type 1
@ast
Life expectancy in Gaucher disease type 1
@en
Life expectancy in Gaucher disease type 1
@nl
P2093
P2860
P356
P1476
Life expectancy in Gaucher disease type 1
@en
P2093
Gregory M Pastores
Katherine A Kacena
Neal J Weinreb
Patrick Deegan
Pramod Mistry
Priscilla Velentgas
Stephan vom Dahl
P2860
P304
P356
10.1002/AJH.21305
P407
P577
2008-12-01T00:00:00Z